-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Initiates Coverage On Adarx Pharmaceuticals with Buy Rating

Benzinga·10/20/2026 14:08:02
TD Cowen analyst Tyler Van Buren initiates coverage on Adarx Pharmaceuticals (NASDAQ:ADRX) with a Buy rating.